Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 10Recruiting 2No longer available 2Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Colorectal Neoplasms 2Unresectable Locally Advanced or Metastatic Solid Tumors 1HER2-positive Colorectal Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Gastrointestinal Stromal Tumors 1Disease Progression 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1

Interventions

Imatinib Mesylate 2regorafenib 1envafolimab 1Mastectomy, Segmental 1Endosonography 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Gastrointestinal Stromal Tumors × regorafenib × Clear all
NCT07379047 2026-04-24

GISTAR-1

Ningbo Newbay Technology Development Co., Ltd

Phase 2/3 Not yet recruiting
255 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡